Wells Fargo Reaffirms Their Buy Rating on AbbVie (ABBV)
TipRanksApr 19 17:45
AbbVie (ABBV) Gets a Buy From Barclays
TipRanksApr 17 15:25
Buy Rating on AbbVie: Resilient Humira Market Position and Promising Pipeline Outlook
TipRanksApr 10 20:25
Analysts Conflicted on These Healthcare Names: Conmed (CNMD), AbbVie (ABBV) and Nurix Therapeutics (NRIX)
TipRanksApr 10 17:10
Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), AbbVie (ABBV) and Immunome (IMNM)
TipRanksApr 8 15:50
Analysts Conflicted on These Healthcare Names: AbbVie (ABBV), Universal Health (UHS) and Teladoc (TDOC)
TipRanksApr 8 15:31
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV) and AbbVie (ABBV)
TipRanksApr 3 17:20
Maintaining Hold Rating on Landos Biopharma Amid Acquisition by AbbVie and Limited Upside Potential
TipRanksApr 1 18:17
AbbVie Analyst Ratings
BenzingaMar 27 19:46
Analysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE) and AbbVie (ABBV)
TipRanksMar 26 09:10
Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV) and Gilead Sciences (GILD)
TipRanksMar 24 17:03
AbbVie Analyst Ratings
BenzingaMar 23 02:01
Analysts' Opinions Are Mixed on These Healthcare Stocks: Incyte (INCY), AbbVie (ABBV) and ACADIA Pharmaceuticals (ACAD)
TipRanksMar 12 20:40
Cerevel Therapeutics: Hold Rating Amidst Pending AbbVie Acquisition
TipRanksMar 7 12:56
Mizuho Raises Price Target on Cerevel Therapeutics to $45 From $25 to Reflect Sale Price to AbbVie, Keeps Neutral Rating
MT NewswiresFeb 15 21:13
Analysts Conflicted on These Healthcare Names: Doximity (DOCS) and AbbVie (ABBV)
TipRanksFeb 9 20:10
AbbVie's Hold Rating Maintained Amid Positive Growth Outlook and Pending Acquisition Outcomes
TipRanksFeb 7 21:27
UBS Adjusts Price Target on AbbVie to $172 From $165, Maintains Neutral Rating
MT NewswiresFeb 7 00:06
AbbVie Analyst Ratings
BenzingaFeb 6 22:13
BofA Raises AbbVie Stock PT but Maintains Neutral Rating, Sees Limited Upside
InvestingFeb 6 02:42
No Data
No Data